Ultralife Corporation
ULBI
$6.94
$0.040.51%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -2.14% | 11.78% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.14% | 11.78% | |||
| Cost of Revenue | 2.50% | 7.92% | |||
| Gross Profit | -16.14% | 25.34% | |||
| SG&A Expenses | 0.70% | -9.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.40% | 4.55% | |||
| Operating Income | -77.13% | 873.95% | |||
| Income Before Tax | 93.50% | -482.87% | |||
| Income Tax Expenses | 93.03% | -446.23% | |||
| Earnings from Continuing Operations | 93.68% | -497.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -35.48% | 14.81% | |||
| Net Income | 93.92% | -508.36% | |||
| EBIT | -77.13% | 873.95% | |||
| EBITDA | -52.01% | 283.24% | |||
| EPS Basic | 93.92% | -508.05% | |||
| Normalized Basic EPS | -93.28% | 388.52% | |||
| EPS Diluted | 93.27% | -508.05% | |||
| Normalized Diluted EPS | -93.28% | 388.52% | |||
| Average Basic Shares Outstanding | 0.02% | 0.05% | |||
| Average Diluted Shares Outstanding | 0.02% | 0.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||